Answers are grounded in this paper and cite their sources.
Nebulisers for the elderly J C Pounsford Asthma mortality in England and Wales is the Hodgkinson's mini mental test, 5 was the best predictor of inability to use a metered dose slowly rising with about 2000 deaths per annum. 1 If these figures are examined with inhaler. In a further study a breath activated and metered dose inhaler was shown to be the respect to age, corrected for population size, mortality in patients over the age of 65 is rising only inhaler that some patients with moderately severe memory loss could use. 6 As 20% of significantly and deaths in those aged over 80 is increasing exponentially. 1 Some "asthma patients over the age of 80 are significantly cognitively impaired, assessment of cognitive deaths" may be explained by changing patterns in death certification with chronic obstructive function becomes an important aspect in the management of patients in whom inhaled ther-pulmonary disease (COPD) being certified as asthma. There is a need to ensure that older apy is being considered. For patients who are cognitively impaired a nebulised broncho-patients are diagnosed accurately and treated in the most appropriate manner.
No takes yet. Share an insight, caveat, or question.
J C Pounsford (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: